In contrast, MDD subtype 2 exhibited PLS1+ gene involvement in calcium signaling, cGMP‐PKG signaling, and MAPK signaling cascades, whereas PLS1− genes engaged in neuroactive ligand–receptor interactions, phospholipase D signaling, and cAMP signaling pathways (Figure 5B). This evidence concerns the gene PLS1 and major depressive disorder.